JulieAMargenthalerMD

Clinical Trials

• Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells Start of enrollment: 2005 Sep 14

  Recruiting

• Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph Nodes Start of enrollment: 2006 Aug 01

  Completed

  Early Phase 1

• Intensity Modulated Radiotherapy for Breast Cancer Start of enrollment: 2008 Jan 04

  Completed

  Phase 1

• Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16

  Completed

  Not Applicable

• Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Start of enrollment: 2012 Jul 01

  Completed

  Phase 2

• PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer Start of enrollment: 2013 Apr 10

  Active, not recruiting

  Phase 2

• LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer Start of enrollment: 2014 Apr 01

  Withdrawn

  Phase 2

• Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells Start of enrollment: 2013 Dec 19

  Terminated

  Phase 2

• Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy Start of enrollment: 2013 Apr 04

  Terminated

  Not Applicable

• Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer Start of enrollment: 2014 Aug 01

  Withdrawn

  Phase 2

• Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction Start of enrollment: 2013 Mar 28

  Completed

  Not Applicable

• Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer Start of enrollment: 2014 Apr 02

  Completed

  Not Applicable

• Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity Start of enrollment: 2014 Jul 07

  Terminated

  Phase 2

• Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy Start of enrollment: 2015 Jan 07

  Active, not recruiting

  Phase 1

• Shave Margins in Breast Conservation Therapy Start of enrollment: 2016 Jun 13

  Terminated

  Phase 2

• Join now to see all